Efficacy Study of Sodium Channel Blocker in LQT3 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01648205
Recruitment Status : Recruiting
First Posted : July 24, 2012
Last Update Posted : December 8, 2017
Gilead Sciences
Information provided by (Responsible Party):
Wojciech Zareba, University of Rochester